These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 26450277)

  • 1. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
    Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
    Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis.
    Sellmann C; Jin CJ; Degen C; De Bandt JP; Bergheim I
    J Nutr; 2015 Oct; 145(10):2280-6. PubMed ID: 26246326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
    Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
    Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
    J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
    Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
    Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.
    Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I
    Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.
    Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I
    J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.
    Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I
    Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation.
    Jin CJ; Engstler AJ; Sellmann C; Ziegenhardt D; Landmann M; Kanuri G; Lounis H; Schröder M; Vetter W; Bergheim I
    Br J Nutr; 2016 Nov; 116(10):1682-1693. PubMed ID: 27876107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
    Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
    J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function.
    Engstler AJ; Sellmann C; Jin CJ; Brandt A; Herz K; Priebs J; Bergheim I
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 28067024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
    Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
    Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability.
    Li J; Sapper TN; Mah E; Moller MV; Kim JB; Chitchumroonchokchai C; McDonald JD; Bruno RS
    J Nutr Biochem; 2017 Mar; 41():34-41. PubMed ID: 28038359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides.
    Beisner J; Filipe Rosa L; Kaden-Volynets V; Stolzer I; Günther C; Bischoff SC
    Front Immunol; 2021; 12():678360. PubMed ID: 34177920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.
    Yamamoto T; Nakade Y; Yamauchi T; Kobayashi Y; Ishii N; Ohashi T; Ito K; Sato K; Fukuzawa Y; Yoneda M
    World J Gastroenterol; 2016 Feb; 22(8):2512-23. PubMed ID: 26937139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
    Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS
    J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.
    Ritze Y; Bárdos G; Hubert A; Böhle M; Bischoff SC
    Br J Nutr; 2014 Jul; 112(1):1-7. PubMed ID: 24708895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice.
    Glisan SL; Ryan C; Neilson AP; Lambert JD
    J Nutr Biochem; 2016 Nov; 37():60-66. PubMed ID: 27619543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.